Helping the public understand adverse events associated with COVID-19 vaccinations: lessons learned from functional neurological disorder
As a physician and communicator, I urge us all: no speculation, only compassion and verified information
D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimers disease mouse model
"This is the first instance where we've seen that semaglutide 2.4 mg enhances cardiovascular outcomes in high-risk patients with a BMI of 27 and above, who have established CVD but do not have diabetes," stated Dr Michael Lincoff, the study's principal author and vice chair for research at Cleveland Clinic's Cardiovascular Medicine Department
377 Vitamin D supplementation has been shown to lower the incidence and benefit MS patients with sufficient evidence, and a Coimbra Protocol referring to daily doses up to 1000 I.U
Indeed, the combined application of BPC-157 and TB-500 is an area of growing interest, suggesting a synergistic approach to advanced regenerative medicine
